
-
No.1 Scheffler goes for third Masters crown in four years
-
Where Trump's tariffs could hurt Americans' wallets
-
Trump says 'very close to a deal' on TikTok
-
Trump tariffs on Mexico: the good, the bad, the unknown
-
Postecoglou denies taunting Spurs fans in Chelsea defeat
-
Oscar-winning Palestinian director speaks at UN on Israeli settlements
-
With tariff war, Trump also reshapes how US treats allies
-
Fernandez fires Chelsea into fourth as pressure mounts on Postecoglou
-
South Korea court to decide impeached president's fate
-
Penguin memes take flight after Trump tariffs remote island
-
E.T., no home: Original model of movie alien doesn't sell at auction
-
Italy's Brignone has surgery on broken leg with Winter Olympics looming
-
Trump defiant as tariffs send world markets into panic
-
City officials vote to repair roof on home of MLB Rays
-
Rockets forward Brooks gets one-game NBA ban for technicals
-
Pentagon watchdog to probe defense chief over Signal chat row
-
US tariffs could push up inflation, slow growth: Fed official
-
New Bruce Springsteen music set for June 27 release
-
Tom Cruise pays tribute to Val Kilmer
-
Mexico president welcomes being left off Trump's tariffs list
-
Zuckerberg repeats Trump visits in bid to settle antitrust case
-
US fencer disqualified for not facing transgender rival
-
'Everyone worried' by Trump tariffs in France's champagne region
-
Italy's Brignone suffers broken leg with Winter Olympics looming
-
Iyer blitz powers Kolkata to big IPL win over Hyderabad
-
Russian soprano Netrebko to return to London's Royal Opera House
-
French creche worker gets 25 years for killing baby with drain cleaner
-
UK avoids worst US tariffs post-Brexit, but no celebrations
-
Canada imposing 25% tariff on some US auto imports
-
Ruud wants 'fair share' of Grand Slam revenue for players
-
Lesotho, Africa's 'kingdom in the sky' jolted by Trump
-
Trump's trade math baffles economists
-
Gaza heritage and destruction on display in Paris
-
'Unprecedented crisis' in Africa healthcare: report
-
Pogacar gunning for blood and thunder in Tour of Flanders
-
Macron calls for suspension of investment in US until tariffs clarified
-
Wall St leads rout as world reels from Trump tariffs
-
Mullins gets perfect National boost with remarkable four-timer
-
Trump tariffs hammer global stocks, dollar and oil
-
Authors hold London protest against Meta for 'stealing' work to train AI
-
Tate Modern gifted 'extraordinary' work by US artist Joan Mitchell
-
Mexico president welcomes being left off Trump's new tariffs list
-
Tonali eager to lead Newcastle back into Champions League
-
Lesotho hardest hit as new US tariffs rattle Africa
-
Stellantis pausing some Canada, Mexico production over Trump auto tariffs
-
Rising odds asteroid that briefly threatened Earth will hit Moon
-
Italy reels from Brignone broken leg with Winter Olympics looming
-
Is the Switch 2 worth the price? Reviews are mixed
-
Ancelotti’s tax trial wraps up in Spain with prosecutors seeking jail
-
Civilians act to bring aid to Myanmar earthquake victims

Seven deaths in E.Guinea from Marburg virus, 20 others likely linked: WHO
Seven people have been killed in an outbreak of Marburg virus in Equatorial Guinea, with a further 20 deaths "probably" due to the hemorrhagic fever, the World Health Organization said Thursday.
The outbreak of the virus, which is almost as deadly as Ebola, has now spread beyond the province of Kie-Ntem, where it caused the first known deaths in January.
It has reached Bata, the economic capital of the small central African country, according to the government.
The spread of Marburg "is a critical signal to scale up response efforts to quickly stop the chain of transmission and avert a potential large-scale outbreak and loss of life," said Dr Matshidiso Moeti, the WHO's regional director for Africa.
Since the start of the outbreak, "there have been a total of nine laboratory-confirmed cases and 20 probable cases", the WHO said in a report on its website.
"Of the nine laboratory-confirmed cases, seven people have died and all probable cases have died."
Among the 20 probable cases, the patients had all the symptoms of the disease and had been in contact with confirmed cases, but samples could not be taken from their bodies, or they could not be treated, a WHO official told AFP Thursday.
The new cases have been reported from Kie-Ntem in the east, Litoral in the west and the Centro Sur provinces, all of which have borders with Cameroon and Gabon.
The epidemic is therefore now a serious problem in three of Equatorial Guinea's four mainland provinces.
- 'High alert' -
In eastern Africa, Tanzania said Tuesday that five people had died from the virus, while neighbouring Uganda, which had its last outbreak in 2017, said it was on "high alert".
The WHO said additional experts in epidemiology, logistics, health operations and infection prevention and control would be deployed in the coming days.
The agency is also supporting the health authorities in neighbouring Cameroon and Gabon to ramp up outbreak readiness and response capabilities.
The Marburg virus causes severe fever, often accompanied by bleeding and organ failure.
It is part of the so-called filovirus family that also includes Ebola, which has wreaked havoc in several previous outbreaks in Africa.
The suspected natural source of the Marburg virus is the African fruit bat, which carries the pathogen but does not fall sick from it.
The virus takes its name from the German city of Marburg, where it was first identified in 1967, in a lab where workers had been in contact with infected green monkeys imported from Uganda.
The animals can pass the virus to primates in close proximity, including humans, and human-to-human transmission then occurs through contact with blood or other body fluids.
Fatality rates in confirmed cases have ranged from 24 percent to 88 percent in previous outbreaks, depending on the virus strain and case management, according to WHO.
There are currently no vaccines or antiviral treatments, but potential treatments, including blood products, immune therapies and drug therapies, as well as early candidate vaccines, are being evaluated, the WHO says.
D.Kaufman--AMWN